eLaws | eCases | United States Code | Federal Courts |
Home » Rulemaking » Prospective Grant of Exclusive License: Use of the Licensed Patent Rights To Develop Fully Human and/or Humanized Monoclonal Antibodies Against IGF-I and/or IGF-II for the Treatment of Human Cancers

Prospective Grant of Exclusive License: Use of the Licensed Patent Rights To Develop Fully Human and/or Humanized Monoclonal Antibodies Against IGF-I and/or IGF-II for the Treatment of Human Cancers

Document ID: NIH_FRDOC_0001-0945
Document Type: Notice
Agency: National Institutes Of Health
Topics: No Topics associated with this document
Federal Register Number: E8-12925
View Document:  View as format pdf View as format html

Details Information

Received Date: June 10 2008, at 07:05 AM Eastern Daylight Time
Start-End Page: 32719 - 32719
Page Count: 1
Comment Start Date: June 10 2008, at 12:00 AM Eastern Standard Time

Comments

Total: 0
No comments posted.

Related Documents

Total: 0
No documents available.